Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity

• Autorzy: Gazarova M. , Bihari M. , Soltis J.
• Języki publikacji: EN

Abstrakty

EN

Background. Fat and fat-free/muscle mass and their ratio reflecting the possible presence of obesity or sarcopenic obesity are important in assessing body composition. Objective. The aim of the work was to assess the use of fat and fat-free mass and their ratio in the diagnosis of sarcopenic obesity, as well as correlations with selected anthropometric, somatic and biochemical parameters and indices. Material and Methods. The object of the study was a group of 201 women (20-68 aged) randomly selected from the population without the presence of a serious disease or without the use of medication. Body composition was assessed by the MFBIA method (InBody 720). We used the ratio of fat to fat-free mass (FM/FFM) to define sarcopenic obesity. A Biolis 24i Premium biochemical analyzer was used to determine biochemical parameters. Results. Using FM and FFM values and their mutual ratio, we identified women with a healthy body weight (28.9%), obese women (58.2%) and women with sarcopenic obesity (12.9%). Values of anthropometric parameters (body weight, BMI, WC, WHR, WHtR, BAI, FM (kg, %), FMI, VFA, FFM (kg), FFMI, SMM (kg), SMMI, ICW, ECW, TBW, CHC, HC), with the exception of FFM (%), SMM (%) and TBW (%), increased significantly with increasing FM/FFM values, so the highest values were found in subjects with sarcopenic obesity. In the case of biochemical parameters, with increasing FM/FFM values, the values of T-CH, LDL, TAG, GLU, hs-CRP, UA, systolic and diastolic blood pressure also increased, so the highest values were again found in women with sarcopenic obesity. HDL values, on the contrary, decreased. FM/ FFM had the strongest positive association with the proportion of fat mass on body weight (r=0.989), then with FMI (r=0.980), FM (r=0.965), VFA (r=0.938), WHtR (r=0.937), BMI (r=0.922), WC (r=0.901. We found the strongest negative association with the proportion of FFM on body weight (r=-0.989), the proportion of total body water (r=-0.988) and the proportion of skeletal muscle mass (r=-0.987). Conclusions. FM/FFM correlates excellently with FM and VFA and can be implemented to diagnose obesity. In order to comprehensively evaluate the state of health and body composition, the proportionality of not only fat, but also fat-free/ muscle mass should be analyzed, because it turns out that a negative impact on health and survival is associated not only with an excessive amount of adipose tissue, but also with a lower muscle mass.

• Wydawca: -
• Czasopismo: Roczniki Państwowego Zakładu Higieny
• Rocznik: 2023
• Tom: 74
• Numer: 1
• Opis fizyczny: p.59-69,fig.,ref.

Twórcy

autor

Gazarova M.

• Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture, Tr.A.Hlinku 2, 949 01 Nitra, Slovak Republic

autor

Bihari M.

• Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture, Tr.A.Hlinku 2, 949 76 Nitra, Slovak Republic

autor

Soltis J.

• Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture, Tr.A.Hlinku 2, 949 76 Nitra, Slovak Republic

Bibliografia

• 1. NCD Risk Factor Collaboration (NCD-RisC): Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016;387(10026):1377-1396. doi:10.1016/S0140-6736(16)30054-X.
• 2. NCD Risk Factor Collaboration (NCD-RisC): Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017;390(10113):2627-2642. doi: 10.1016/S0140-6736(17)32129-3.
• 3. Blüher, M.: Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. doi:10.1038/s41574-019-0176-8.
• 4. World Health Organisation, European Regional Obesity Report 2022: WHO Regional Office for Europe, Copenhagen 2022.
• 5. Allott, E.H., Hursting, S.D.: Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr Relat Cancer 2015;22(6):R365-386. doi: 10.1530/ERC-15-0400.
• 6. O’Neill, S., O’Driscoll, L.: Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1-12. doi: 10.1111/obr.12229.
• 7. Sakuma, K., Yamaguchi, A.: Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol. 2013;2013:204164. doi: 10.1155/2013/204164.
• 8. Blüher, M., Mantzoros, C.S.: From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64(1):131-145. doi: 10.1016/j.metabol.2014.10.016.
• 9. Florez, H., Troen, B.R.: Fat and inflammaging: a dual path to unfitness in elderly people? J Am Geriatr Soc. 2008;56(3):558-560. doi: 10.1111/j.1532-5415.2007.01584.x.
• 10. Tateya, S., Kim, F., Tamori, Y.: Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) 2013;4:93. doi: 10.3389/fendo.2013.00093.
• 11. Lackey, D., Olefsky, J.: Regulation of metabolism by the innate immune system. Nat Rev Endocrinol 2016;12:15-28. https://doi.org/10.1038/nrendo.2015.189.
• 12. Beyer, I., Mets, T., Bautmans, I.: Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012;15(1):12-22. doi: 10.1097/MCO.0b013e32834dd297.
• 13. Chen, L., Chen, R., Wang, H., Liang, F.: Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol. 2015;2015:508409. doi: 10.1155/2015/508409.
• 14. Tanimoto, Y., Watanabe, M., Sun, W., Sugiura, Y., Hayashida, I., Kusabiraki, T., Tamaki, J.: Sarcopenia and falls in community-dwelling elderly subjects in Japan: Defining sarcopenia according to criteria of the European Working Group on Sarcopenia in Older People. Arch Gerontol Geriatr. 2014;59(2):295-299. doi: 10.1016/j.archger.2014.04.016.
• 15. Giglio, J., Kamimura, M.A., Lamarca, F., Rodrigues, J., Santin, F., Avesani, C.M.: Association of Sarcopenia With Nutritional Parameters, Quality of Life, Hospitalization, and Mortality Rates of Elderly Patients on Hemodialysis. J Ren Nutr. 2018;28(3):197-207. doi: 10.1053/j.jrn.2017.12.003.
• 16. Cawthon, P.M., Lui, L.Y., Taylor, B.C., McCulloch, C.E., Cauley, J.A., Lapidus, J., Orwoll, E., Ensrud, K.E.: Clinical Definitions of Sarcopenia and Risk of Hospitalization in Community-Dwelling Older Men: The Osteoporotic Fractures in Men Study. J Gerontol A Biol Sci Med Sci. 2017;72(10):1383-1389. doi: 10.1093/gerona/glw327.
• 17. Liu, P., Hao, Q., Hai, S., Wang, H., Cao, L., Dong, B.: Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: A systematic review and meta-analysis. Maturitas 2017;103:16-22. doi: 10.1016/j.maturitas.2017.04.007.
• 18. Bosy-Westphal, A., Müller, M.J.: Diagnosis of obesity based on body composition-associated health risks-Time for a change in paradigm. Obes Rev. 2021;22 Suppl 2:e13190. doi:10.1111/obr.13190.
• 19. Donini, L.M., Busetto, L., Bischoff, S.C., Cederholm, T., Ballesteros-Pomar, M.D., Batsis, J. A. et al.: Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321-335. doi:10.1159/000521241.
• 20. Gonzalez, M.C., Pastore, C.A., Orlandi, S.P., Heymsfield, S.B.: Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99(5):999-1005. doi:10.3945/ajcn.113.071399.
• 21. Kaeberlein, M., Rabinovitch, P.S., Martin, G.M.: Healthy aging. The ultimate preventative medicine. Science 2015;350(6265):1191-1193. doi: 10.1126/science.aad3267.
• 22. Santilli, V., Bernetti, A., Mangone, M., Paoloni, M.: Clinical definition ofsarcopenia. Clin. Cases Miner. Bone Metab. 2014;11(3):177-180.
• 23. Beaudart, C., Rizzoli, R., Bruyère, O., Reginster, J.Y., Biver, E.: Sarcopenia: burden and challenges for public health. Arch Public Health 2014;72(1):45. doi: 10.1186/2049-3258-72-45.
• 24. Cesari, M., Landi, F., Vellas, B., Bernabei, R., Marzetti, E.: Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014;6:192. doi: 10.3389/fnagi.2014.00192.
• 25. Tian, S., Xu, Y.: Association of sarcopenic obesity with the risk of all-cause mortality: A meta-analysis of prospective cohort studies. Geriatr Gerontol Int. 2016;16(2):155-166. doi:10.1111/ggi.12579.
• 26. Kalinkovich, A., Livshits, G.: Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200-221. doi: 10.1016/j.arr.2016.09.008.
• 27. Stenholm, S., Harris, T.B., Rantanen, T., Visser, M., Kritchevsky, S.B., Ferrucci, L.: Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008;11(6):693-700. doi: 10.1097/MCO.0b013e328312c37d.
• 28. Waters, D.L., Baumgartner, R.N.: Sarcopenia and obesity. Clin Geriatr Med. 2011;27(3):401-421. doi: 10.1016/j.cger.2011.03.007.
• 29. Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., Di Francesco, V.: Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-395. doi: 10.1016/j.numecd.2007.10.002.
• 30. Kim, T.N., Yang, S.J., Yoo, H.J., Lim, K.I., Kang, H.J., Song, W., Seo, J.A., Kim, S.G., Kim, N.H., Baik, S.H., Choi, D.S., Choi, K.M.: Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009;33(8):885-892. doi: 10.1038/ijo.2009.130.
• 31. Dominguez, L.J., Barbagallo, M.: The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183-189. doi: 10.1111/j.1559-4564.2007.06673.x.
• 32. Johnson Stoklossa, C.A., Sharma, A.M., Forhan, M., Siervo, M., Padwal, R.S., Prado, C.M.: Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria. J Nutr Metab. 2017;2017:7307618. doi: 10.1155/2017/7307618.
• 33. Baumgartner, R.N.: Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437-448. doi: 10.1111/j.1749-6632.2000.tb06498.x.
• 34. Flegal, K.M., Carroll, M.D., Ogden, C.L., Johnson, C.L.: Prevalence and Trends in Obesity Among US Adults, 1999-2000. JAMA 2002;288(14):1723-1727. doi:10.1001/jama.288.14.1723.
• 35. Villareal, D.T., Shah, K.: Obesity in Older Adults – A Growing Problem. In: Bales, C., Ritchie, C. (eds). Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, Totowa, 2009. https://doi.org/10.1007/978-1-60327-385-5_15.
• 36. Roubenoff, R.: Sarcopenic obesity: the confluence of two epidemics. Obes Res. 2004;12(6):887-888. doi: 10.1038/oby.2004.107.
• 37. Skrzypczak, M., Szwed, A., Pawlińska-Chmara, R., Skrzypulec, V.: Assessment of the BMI, WHR and W/Ht in pre- and post-menopausal women. Anthropol. Rev. 2007;70:3-13.
• 38. DAPA Toolkit. 2022. Diet, Anthropometry and Physical Activity Measurement Toolkit. Available on: https://dapa-toolkit.mrc.ac.uk/anthropometry/introduction/anthropometry.
• 39. World Health Organization, “Waist circumference and waist-hip-ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008,” Tech. Rep., World Health Organization, 2011. http://apps.who.int/iris/handle/10665/44583.
• 40. World Health Organization. Obesity and overweight. 2020. Available on: https://www.who.int/en/newsroom/fact-sheets/detail/obesity-and-overweight.
• 41. Krakauer, N.Y., Krakauer, J.C.: A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504. doi:10.1371/journal.pone.0039504.
• 42. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: National Health and Medical Research Council; 2013. Available on: https://www.nhmrc.gov.au/about-us/publications/clinical-practice-guidelines-managementoverweightand-obesity.
• 43. Prado, C.M., Wells, J.C., Smith, S.R., Stephan, B.C., Siervo, M.: Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012;31(5):583-601. doi:10.1016/j.clnu.2012.06.010.
• 44. Gomez-Peralta, F., Abreu, C., Cruz-Bravo, M., Alcarria, E., Gutierrez-Buey, G., Krakauer, N. Y., Krakauer, J. C.: Relationship between “a body shape index (ABSI)” and body composition in obese patients with type 2 diabetes. Diabetol Metab Syndr. 2018;10:21. doi:10.1186/s13098-018-0323-8.
• 45. Kutáč. P.: Základy kinantropometrie [Basics of kinanthropometry] (1st ed.). Ostrava: PdF Ostravské univerzity, 2009;87 pp. ISBN 978-80-7368-726-7 (in Slovak).
• 46. Forbes, G.: Longitudinal changes in adult fat-free mass: influence of body weight. In The American Journal of Clinical Nutrition 1999;70(6):1025-1031. https://doi. org/10.1093/ajcn/70.6.1025.
• 47. Schutz, Y., Woringer, V.: Obesity in Switzerland: a critical assessment of prevalence in children and adults. Int J Obes Relat Metab Disord. 2002;26(Suppl 2):S3-S11. doi: 10.1038/sj.ijo.0802122.
• 48. Bouchard, D.R., Dionne, I.J., Brochu, M.: Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring). 2009;17(11):2082-2088. doi: 10.1038/oby.2009.109.
• 49. Lee, J., Hong, Y.P., Shin, H.J., Lee, W.: Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength. J Prev Med Public Health. 2016;49(1):35-44. doi: 10.3961/jpmph.15.055.
• 50. Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T. et al.: Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16-31. doi: 10.1093/ageing/afy169.
• 51. Lutz, C.T., Quinn, L.S.: Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY) 2012;4(8):535-546. doi: 10.18632/aging.100482.
• 52. Schrager, M.A., Metter, E.J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., Ferrucci, L.: Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007;102(3):919-925. doi: 10.1152/japplphysiol.00627.2006.
• 53. Cesari, M., Kritchevsky, S.B., Baumgartner, R.N., Atkinson, H.H., Penninx, B.W., Lenchik, L., Palla, S.L., Ambrosius, W.T., Tracy, R.P., Pahor, M.: Sarcopenia, obesity, and inflammation-results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005;82(2):428-434. doi: 10.1093/ajcn.82.2.428.
• 54. Kim, T.N., Won, J.C., Kim, Y.J., Lee, E.J., Kim, M.K., Park, M.S., Lee, S.K., Kim, J.M., Ko, K.S., Rhee, B.D.: Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity. Diabetes Res Clin Pract. 2013;101(2):210-217. doi:10.1016/j.diabres.2013.05.014.
• 55. Biolo, G., Di Girolamo, F.G., Breglia, A., Chiuc, M., Baglio, V., et al.: Inverse relationship between “a body shape index” (ABSI) and fat-free mass in women and men: Insights into mechanisms of sarcopenic obesity. Clin Nutr. 2015;34(2):323-327. doi:10.1016/j.clnu.2014.03.015.
• 56. Khera, A., Vega, G.L., Das, S.R., Ayers, C., McGuire, D.K., et al.: Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab. 2009;94(9):3251-3258. doi:10.1210/jc.2008-2406.
• 57. Biolo, G., Ciocchi, B., Stulle, M., Piccoli, A., Lorenzon, S., et al.: Metabolic consequences of physical inactivity. J Ren Nutr. 2005;15(1):49-53. doi:10.1053/j.jrn.2004.09.009.
• 58. Dominguez, L.J., Barbagallo, M.: The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183-189. doi: 10.1111/j.1559-4564.2007.06673.x.
• 59. Rolland, Y., Lauwers-Cances, V., Cristini, C., Abellan van Kan, G., Janssen, I., Morley, J.E., Vellas, B.: Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr. 2009;89(6):1895-1900. doi: 10.3945/ajcn.2008.26950.
• 60. Olsen, R.H., Krogh-Madsen, R., Thomsen, C., Booth, F.W., Pedersen, B.K.: Metabolic responses to reduced daily steps in healthy nonexercising men. JAMA. 2008;299(11):1261-1263. doi:10.1001/jama.299.11.1259.
• 61. Biolo, G., Agostini, F., Simunic, B., Sturma, M., Torelli, L., et al.: Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr. 2008;88(4):950-958. doi:10.1093/ajcn/88.4.950.

Identyfikatory

DOI

10.32394/rpzh.2023.0243